BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TRANSGENE S.A. 

11 rue de MOLSHEIM, 67082
Strasbourg
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Gene Therapy

Collaborations

Human Genome Sciences, Inc.  Gene Therapy Partnerships





 Company News
TRANSGENE (ENX:TNG) Reports Financial Results For First Six Months Of 2014 And Provides Update On TG4010 9/9/2014 11:18:42 AM
TRANSGENE (ENX:TNG)-Tasly Pharmaceutical JV Reports Immunotherapy Progress 7/2/2014 11:52:19 AM
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014 10:46:07 AM
TRANSGENE (ENX:TNG) Announces Promising Results In An Update From The Phase 2b Part Of TIME Trial With TG4010 In Advanced Non-Small Cell Lung Cancer 5/27/2014 10:40:15 AM
TRANSGENE (ENX:TNG) Reports Progress With Its Proprietary Oncolytic Immunotherapy To Treat Solid Tumors 5/15/2014 12:06:49 PM
TRANSGENE (ENX:TNG) Announces Presentations At Upcoming Investor Conferences 5/12/2014 9:59:59 AM
TRANSGENE (ENX:TNG) Drops As Novartis AG (NVS) Decides To Pass On Bypass Drug; Stock Down -17.98% At Market Close (April 29, 2014) 4/29/2014 8:13:22 AM
TRANSGENE (ENX:TNG) Reports First Quarter 2014 Financial Results 4/22/2014 10:07:13 AM
TRANSGENE (ENX:TNG) Reports Fiscal Year 2013 Results And Provides Business Update 3/27/2014 6:58:03 AM
Global Partners SillaJen, TRANSGENE (ENX:TNG) And TRANSGENE (ENX:TNG) Confirm Clinical Development Plan For Pexa-Vec 3/26/2014 9:53:54 AM
12345678910...